Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Fleishaker, JC' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 54 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Fleishaker, JC; Sisson, TA; Carel, BJ; Azie, NE
      Lack of pharmacokinetic interaction between the antimigraine compound, almotriptan, and propranolol in healthy volunteers

      CEPHALALGIA
    2. Fleishaker, JC; Ryan, KK; Jansat, JM; Carel, BJ; Bell, DJA; Burke, MT; Azie, NE
      Effect of MAO-A inhibition on the pharmacokinetics of almotriptan, an antimigraine agent in humans

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    3. Fleishaker, JC; Ryan, KK; Carel, BJ; Azie, NE
      Evaluation of the potential pharmacokinetic interaction between almotriptan and fluoxetine in healthy volunteers

      JOURNAL OF CLINICAL PHARMACOLOGY
    4. Fleishaker, JC; Francom, SF; Herman, BD; Knuth, DW; Azie, NE
      Lack of effect of reboxetine on cardiac repolarization

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    5. Hendershot, PE; Fleishaker, JC; Lin, KM; Nuccio, ID; Poland, RE
      Pharmacokinetics of reboxetine in healthy volunteers with different ethnicdescents

      PSYCHOPHARMACOLOGY
    6. Tran, A; Laneury, JP; Duchene, P; Jannuzzo, MG; Fleishaker, JC; Houin, G; Rampal, P
      Pharmacokinetics of reboxetine in volunteers with hepatic impairment

      CLINICAL DRUG INVESTIGATION
    7. Fleishaker, JC
      Pharmacokinetics and metabolism of reboxetine

      REVIEWS IN CONTEMPORARY PHARMACOTHERAPY
    8. Poggesi, I; Pellizzoni, C; Fleishaker, JC
      Pharmacokinetics of reboxetine in elderly patients with depressive disorders

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    9. Bergmann, JF; Laneury, JP; Duchene, P; Fleishaker, JC; Houin, G; Segrestaa, JM
      Pharmacokinetics of reboxetine in healthy, elderly volunteers

      EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
    10. Fleishaker, JC
      Clinical pharmacokinetics of reboxetine, a selective norepinephrine reuptake inhibitor for the treatment of patients with depression

      CLINICAL PHARMACOKINETICS
    11. Coulomb, F; Ducret, F; Laneury, JP; Fiorentini, F; Poggesi, I; Jannuzzo, MG; Fleishaker, JC; Houin, G; Duchene, P
      Pharmacokinetics of single-dose reboxetine in volunteers with renal insufficiency

      JOURNAL OF CLINICAL PHARMACOLOGY
    12. Fleishaker, JC; Sisson, TA; Carel, BJ; Azie, NE
      Pharmacokinetic interaction between verapamil and almotriptan in healthy volunteers

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    13. Fleishaker, JC; Herman, BD; Pearson, LK; Ionita, A; Mucci, M
      Evaluation of the potential pharmacokinetic/pharmacodynamic interaction between fluoxetine and reboxetine in healthy volunteers

      CLINICAL DRUG INVESTIGATION
    14. Fleishaker, JC; Pearson, LK; Knuth, DW; Gomez-Mancilla, B; Francom, SF; McIntosh, MJ; Freestone, S; Azie, NE
      Pharmacokinetics and tolerability of a novel 5-HT1D agonist, PNU-142633F

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    15. Fleishaker, JC; Fiedler-Kelly, J; Grasela, TH
      Population pharmacokinetics of tirilazad: Effects of weight, gender, concomitant phenytoin, and subarachnoid hemorrhage

      PHARMACEUTICAL RESEARCH
    16. Fleishaker, JC; Mucci, M; Pellizzoni, C; Poggesi, I
      Absolute bioavailability of reboxetine enantiomers and effect of gender onpharmacokinetics

      BIOPHARMACEUTICS & DRUG DISPOSITION
    17. Fleishaker, JC; Pearson, LK; Pearson, PG; Wienkers, LC; Hopkins, NK; Peters, GR
      Hormonal effects on tirilazad clearance in women: Assessment of the role of CYP3A

      JOURNAL OF CLINICAL PHARMACOLOGY
    18. Herman, BD; Fleishaker, JC; Brown, MT
      Ketoconazole inhibits the clearance of the enantiomers of the antidepressant reboxetine in humans

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    19. FLEISHAKER JC; PEARSON LK; PETERS GR
      INDUCTION OF TIRILAZAD CLEARANCE BY PHENYTOIN

      Biopharmaceutics & drug disposition
    20. Venkatakrishnan, K; Von Moltke, LL; Duan, SX; Fleishaker, JC; Shader, RI; Greenblatt, DJ
      Kinetic characterization and identification of the enzymes responsible forthe hepatic biotransformation of adinazolam and N-desmethyladinazolam in man

      JOURNAL OF PHARMACY AND PHARMACOLOGY
    21. WIENKERS LC; STEENWYK RC; HAUER MJ; FLEISHAKER JC; PEARSON PG
      BIOTRANSFORMATION OF TIRILAZAD IN HUMAN - 3 - TIRILAZAD A-RING REDUCTION BY HUMAN LIVER MICROSOMAL 5-ALPHA-REDUCTASE TYPE-1 AND TYPE-2

      The Journal of pharmacology and experimental therapeutics
    22. FLEISHAKER JC; PEARSON PG; WIENKERS LC; PEARSON LK; MOORE TA; PETERS GR
      BIOTRANSFORMATION OF TIRILAZAD IN HUMAN - 4 - EFFECT OF FINASTERIDE ON TIRILAZAD CLEARANCE AND REDUCED METABOLITE FORMATION

      The Journal of pharmacology and experimental therapeutics
    23. FLEISHAKER JC; PETERS GR
      PHARMACOKINETICS OF TIRILAZAD IN HEALTHY MALE-SUBJECTS AT DOSES ABOVE6 MG KG/DAY/

      International journal of clinical pharmacology and therapeutics
    24. WRIGHT CE; SISSON TL; FLEISHAKER JC; ANTAL EJ
      PHARMACOKINETICS AND PSYCHOMOTOR PERFORMANCE OF ALPRAZOLAM - CONCENTRATION-EFFECT RELATIONSHIP

      Journal of clinical pharmacology
    25. FLEISHAKER JC; STRAW RN; CROSS CJ
      PHARMACOKINETICS OF TIRILAZAD AND U-89678, AN ACTIVE, REDUCED METABOLITE, FOLLOWING ACUTE HEAD TRAUMA IN ADULTS

      Journal of pharmaceutical sciences
    26. FLEISHAKER JC; PEARSON LK; PEARSON PG; WIENKERS LC; MOORE TA; PETERS GR
      FINASTERIDE INHIBITS FORMATION OF REDUCED ACTIVE METABOLITES OF TIRILAZAD

      Clinical pharmacology and therapeutics
    27. AJIR K; SMITH M; LIN KM; FLEISHAKER JC; CHAMBERS JH; ANDERSON D; NUCCIO I; ZHENG YP; POLAND RE
      THE PHARMACOKINETICS AND PHARMACODYNAMICS OF ADINAZOLAM - MULTIETHNICCOMPARISONS

      Psychopharmacology
    28. FLEISHAKER JC; PETERS GR
      PHARMACOKINETICS OF TIRILAZAD AND U-89678 IN ISCHEMIC STROKE PATIENTSRECEIVING A LOADING REGIMEN AND MAINTENANCE REGIMEN OF 10 MG KG/DAY OF TIRILAZAD/

      Journal of clinical pharmacology
    29. PEARSON LK; FLEISHAKER JC; PETERS GR
      COMPARISON OF THE PHARMACOKINETICS OF TIRILAZAD MESYLATE IN HEALTHY-VOLUNTEERS AND STABLE SUBJECTS WITH MILD LIVER-CIRRHOSIS

      European Journal of Clinical Pharmacology
    30. FLEISHAKER JC; PEARSON LK; PETERS GR
      GENDER DOES NOT AFFECT THE DEGREE OF INDUCTION OF TIRILAZAD CLEARANCEBY PHENOBARBITAL

      European Journal of Clinical Pharmacology
    31. FLEISHAKER JC; PEARSON PG; WIENKERS LC; PEARSON LK; PETERS GR
      BIOTRANSFORMATION OF TIRILAZAD IN HUMAN .2. EFFECT OF KETOCONAZOLE ONTIRILAZAD CLEARANCE AND ORAL BIOAVAILABILITY

      The Journal of pharmacology and experimental therapeutics
    32. FLEISHAKER JC; PEARSON LK; PETERS GR
      EFFECT OF GENDER ON THE DEGREE OF INDUCTION OF TIRILAZAD CLEARANCE BYPHENYTOIN

      Clinical pharmacology and therapeutics
    33. FLEISHAKER JC; PETERS GR
      PHARMACOKINETICS OF TIRILAZAD AND U-89678 IN ISCHEMIC STROKE PATIENTS

      Clinical pharmacology and therapeutics
    34. GREENBLATT DJ; EHRENBERG BL; HARMATZ JS; FLEISHAKER JC; CORBETT K; HARREL L; SHADER RI
      COMPARATIVE PHARMACODYNAMICS OF INTRAVENOUS ALPRAZOLAM, ADINAZOLAM, DESMETHYLADINAZOLAM, AND PLACEBO

      Clinical pharmacology and therapeutics
    35. DOBBS FR; BANKS W; FLEISHAKER JC; VALENTINE AD; KINSEY BM; FRANCESCHINI MP; DIGENIS GA; TEWSON TJ
      STUDIES WITH [C-11] ALPRAZOLAM - AN AGONIST FOR THE BENZODIAZEPINE RECEPTOR

      Nuclear medicine and biology
    36. FLEISHAKER JC; CHAMBERS JH; PETERS GR
      EVALUATION OF THE DEVELOPMENT OF ACUTE TOLERANCE TO THE PSYCHOMOTOR EFFECTS OF MIDAZOLAM FOLLOWING INTRAVENOUS INFUSIONS IN HEALTHY-VOLUNTEERS

      Human psychopharmacology
    37. FLEISHAKER JC; PEARSON LK; PETERS GR
      PHENYTOIN CAUSES A RAPID INCREASE IN 6-BETA-HYDROXYCORTISOL URINARY-EXCRETION IN HUMANS - A PUTATIVE MEASURE OF CYP3A INDUCTION

      Journal of pharmaceutical sciences
    38. MUMFORD GK; EVANS SM; FLEISHAKER JC; GRIFFITHS RR
      ALPRAZOLAM ABSORPTION KINETICS AFFECTS ABUSE LIABILITY

      Clinical pharmacology and therapeutics
    39. FLEISHAKER JC; PEARSON LK
      EFFECT OF GENDER ON THE DEGREE OF INDUCTION OF TIRILAZAD CLEARANCE BYPHENOBARBITAL

      Clinical pharmacology and therapeutics
    40. FLEISHAKER JC; GARZONE PD; CHAMBERS JH; SIROCCO K; WEINGARTNER H
      COMPARISON OF THE SPECTRUM OF COGNITIVE EFFECTS OF ALPRAZOLAM AND ADINAZOLAM AFTER SINGLE DOSES IN HEALTHY-SUBJECTS

      Psychopharmacology
    41. FLEISHAKER JC; HULST LK; PETERS GR
      MULTIPLE-DOSE TOLERABILITY AND PHARMACOKINETICS OF TIRILAZAD MESYLATEAT DOSES OF UP TO 10 MG KG/DAY ADMINISTERED OVER 5-10 DAYS IN HEALTHY-VOLUNTEERS/

      International journal of clinical pharmacology and therapeutics
    42. FLEISHAKER JC; HULST LK; PETERS GR
      LACK OF PHARMACOKINETIC INTERACTION BETWEEN CIMETIDINE AND TIRILAZAD MESYLATE

      Pharmaceutical research
    43. FLEISHAKER JC; GREIST JH; JEFFERSON JW; SHERIDAN AQ
      RELATIONSHIP BETWEEN CONCENTRATIONS OF ADINAZOLAM AND ITS PRIMARY METABOLITE IN PLASMA AND THERAPEUTIC UNTOWARD EFFECTS IN THE TREATMENT OFPANIC DISORDER/

      Journal of clinical psychopharmacology
    44. CHAMBERS JH; FLEISHAKER JC
      THE LACK OF EFFECT OF SMOKING ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF ADINAZOLAM AND N-DEMETHYLADINAZOLAM

      Biopharmaceutics & drug disposition
    45. FLEISHAKER JC; HULST LK; PETERS GR
      LACK OF A PHARMACOKINETIC PHARMACODYNAMIC INTERACTION BETWEEN NIMODIPINE AND TIRILAZAD MESYLATE IN HEALTHY-VOLUNTEERS/

      Journal of clinical pharmacology
    46. FLEISHAKER JC; HULST LK
      A PHARMACOKINETIC AND PHARMACODYNAMIC EVALUATION OF THE COMBINED ADMINISTRATION OF ALPRAZOLAM AND FLUVOXAMINE

      European Journal of Clinical Pharmacology
    47. FLEISHAKER JC; HULST LK; PETERS GR
      THE EFFECT OF PHENYTOIN ON THE PHARMACOKINETICS OF TIRILAZAD MESYLATEIN HEALTHY MALE-VOLUNTEERS

      Clinical pharmacology and therapeutics
    48. GOLDEN PL; WARNER PE; FLEISHAKER JC; JEWELL RC; MILLIKIN S; LYON J; BROUWER KLR
      EFFECTS OF PROBENECID ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OFADINAZOLAM IN HUMANS

      Clinical pharmacology and therapeutics
    49. HULST LK; FLEISHAKER JC; PETERS GR; HARRY JD; WRIGHT DM; WARD P
      EFFECT OF AGE AND GENDER ON TIRILAZAD PHARMACOKINETICS IN HUMANS

      Clinical pharmacology and therapeutics
    50. MUMFORD GK; EVANS SM; FLEISHAKER JC; GRIFFITHS RR
      ALPRAZOLAM ABSORPTION KINETICS AFFECTS ABUSE LIABILITY

      Clinical pharmacology and therapeutics
    51. FLEISHAKER JC; CHAMBERS JH
      DEGREE AND EXPOSURE DURATION AFFECT TOLERANCE TO MIDAZOLAMS PSYCHOMOTOR EFFECTS

      Clinical pharmacology and therapeutics
    52. FLEISHAKER JC; CHAMBERS JH; GARZONE PD; WEINGARTNER HJ
      COMPARATIVE EFFECTS OF ALPRAZOLAM AND ADINAZOLAM ON MEMORY AND PSYCHOMOTOR PERFORMANCE

      Clinical pharmacology and therapeutics
    53. STAHL SM; HAUGER RL; RAUSCH JL; FLEISHAKER JC; HUBBELLALBERTS E
      DOWN-REGULATION OF SEROTONIN RECEPTOR SUBTYPES BY NORTRIPTYLINE AND ADINAZOLAM IN MAJOR DEPRESSIVE DISORDER - NEUROENDOCRINE AND PLATELET MARKERS

      Clinical neuropharmacology
    54. FLEISHAKER JC; SISSON TA; SRAMEK JJ; CONRAD J; VEROFF AE; CUTLER NR
      PSYCHOMOTOR AND MEMORY EFFECTS OF 2 ADINAZOLAM FORMULATIONS ASSESSED BY A COMPUTERIZED NEUROPSYCHOLOGICAL TEST BATTERY

      Journal of clinical pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/06/20 alle ore 21:59:17